At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 90 enrolled
Drug / intervention
Copper IUD placement at time Cesarean Delivery (Copper T 380A)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transcesarean IUD Insertion: A Prospective Cohort Study
In Brief
A Phase 4 clinical trial evaluating Copper IUD placement at time Cesarean Delivery (Copper T 380A) for Intrauterine Device Expulsion. Completed, enrolled 90 participants across 2 sites.
Detailed Summary
The purpose of this study is to determine the expulsion rates of copper Intrauterine Devices (IUDs) placed at time of Cesarean Delivery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntrauterine Device Expulsion
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2008
Primary CompletionNov 2009
Study CompletionMay 2010
First PostedSep 2011
TodayJul 2026
First PostedSep 23, 2011
Enrollment StartAug 1, 2008
Primary CompletionNov 1, 2009
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.8 years ago
Interventions
Copper IUD placement at time Cesarean Delivery (Copper T 380A)device
Placement of Paragard IUD at time of Cesarean Delivery